Peri Operative Smoking Cessation Program
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02053155|
Recruitment Status : Completed
First Posted : February 3, 2014
Last Update Posted : December 4, 2015
|Condition or disease||Intervention/treatment||Phase|
|Smoking Cessation||Behavioral: Computer based patient education||Not Applicable|
Patients will be enrolled in the quit smoking before surgery program. Before participating in the education program, the investigators will ask patients questions about their smoking habits, and patient will complete pre-education questionnaires that should take about 5 minutes. Patients will participate in a computer-based education program about quitting smoking for about 15 minutes. It will explain the importance of quitting smoking before their surgery, how to quit and coping with quitting. If they are not familiar with using a computer, we will provide an assistant for them to complete the education program. After completing the education program, they will complete a post-education questionnaire. patients will also receive an information pamphlet.
All participants will receive the computer-based education program, brief counselling, pamphlet, Smokers' Helpline referral, and telephone follow-up.
Altogether you will be spending about 30 minutes to complete the assessment, education program and counselling.
patients will be asked for their permission to inform their family physician about their participation in this study. Their smoking status, date of surgery, quit date, and recommended medication (when appropriate) will be faxed to your family physician to assist them quitting process. If they are willing to accept the assistance from Smokers' Helpline, their name and phone number will be faxed to the Smokers' Helpline, and someone from Smokers' Helpline will call you in the next 48 hours to follow-up.
The investigators will monitor patient's smoking behavior by measuring expired carbon monoxide, a gas in the air they breathe out, during their pre-surgery visit and on the day of surgery. We also will measure urine cotinine (a by-product of nicotine) by taking urine samples and check their smoking status by asking questions about their smoking habits on the day of surgery, 1 month, 3 months and 6 months after their surgery. During the telephone interview follow-up, we will remind them to do the urine cotinine and mail it to us. (Prepaid mail with urine cotinine strip will be provided at the time of the 2nd visit on the day of surgery.) Each follow-up phone call will take about 6 -10 minutes.
A one-month,3 month and 6 month follow up will be done by the research coordinator to assess the smoking status. Brief counseling (< 5 mins) will be provided.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||345 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Development and Implementation of a Peri Operative Smoking Cessation Program With Computer Based Patient Education.|
|Study Start Date :||July 2013|
|Actual Primary Completion Date :||June 2015|
|Actual Study Completion Date :||June 2015|
Experimental: computer based patient education
The patients will complete a pre module and post module set of questions to determine whether their knowledge about peri operative smoking cessation increase smoking has changed. According to their willingness and eligibility, pharmacotherapy will be given.
|Behavioral: Computer based patient education|
- Quit rate [ Time Frame: 6 month ]we will do urine cotinine analysis to confirm the abstinence
- Surgical outcome [ Time Frame: 1 month ]we will do a chart review to find out the intraoperative and post operative complications
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02053155
|Mount Sinai Hospital|
|Toronto, Ontario, Canada, M5G 1X5|
|Toronto Western Hospital|
|Toronto, Ontario, Canada|
|Womens College Hospital|
|Toronto, Ontario, Canada|
|Principal Investigator:||Jean Wong, FRCPC||Associate professor, dewpartment of anesthesia. Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario|